EBSCN(601788)
Search documents
光大证券股价下跌0.94% 研究所所长高瑞东转战光大保德信基金
Sou Hu Cai Jing· 2025-08-21 19:06
光大证券股价报18.89元,较前一交易日下跌0.18元,跌幅0.94%。当日开盘价为19.17元,最高触及 19.25元,最低下探至18.75元,成交量为509748手,成交金额达9.68亿元。 光大证券研究所所长、首席经济学家高瑞东已卸任现职,将加盟光大保德信基金并拟任总经理。高瑞东 是业内知名的研究型管理人才,曾担任财政部金融人才库专家等职务。光大证券研究所日常事务将由副 所长王一峰接管。光大保德信基金是光大证券与美国保德信国际投资管理公司合资设立的基金管理公 司,截至2025年二季度末管理资产总规模达956亿元。 光大证券当日主力资金净流出9721.24万元,占流通市值的0.13%。近五个交易日主力资金累计净流出 34274.16万元,占流通市值的0.46%。 风险提示:市场有风险,投资需谨慎。 来源:金融界 光大证券属于证券行业板块,是中国领先的综合金融服务提供商。公司业务涵盖证券经纪、投资银行、 资产管理、自营交易等多个领域,为境内外客户提供全方位的金融服务。光大证券旗下拥有光大保德信 基金等子公司,在资产管理领域具有一定市场地位。 ...
秀强股份: 光大证券股份有限公司关于江苏秀强玻璃工艺股份有限公司2025年半年度跟踪报告
Zheng Quan Zhi Xing· 2025-08-21 16:48
Group 1 - The sponsorship work overview indicates that the company has timely reviewed information disclosure documents and has not missed any reviews [1] - The company has established and effectively executed regulations to prevent related party transactions and manage fundraising [1] - The company has conducted one inquiry into the special fundraising account and confirmed that the project progress aligns with the disclosed information [1] Group 2 - There are no reported issues or concerns regarding the company's operations or compliance with regulations [3] - The company has not failed to fulfill any commitments made by the company or its shareholders [3] - No significant changes in financial status, management, or core technology have been reported [3]
映翰通: 光大证券股份有限公司关于北京映翰通网络技术股份有限公司部分募投项目结项并将节余募集资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-21 16:39
Core Viewpoint - The company has completed certain fundraising projects and plans to permanently supplement its working capital with the remaining funds, which is expected to enhance the efficiency of fund utilization without significantly impacting normal operations [8]. Fundraising Basic Situation - The company raised a total of RMB 362.15 million through its initial public offering, with a net amount of RMB 313.72 million after deducting issuance costs [1][2]. - The funds were deposited in a special account approved by the board and are subject to a tripartite supervision agreement with the sponsor and the bank [2]. Fundraising Investment Project Situation Investment Projects - The total investment amount for the fundraising projects is RMB 283.08 million, with RMB 263.35 million planned for use [2]. - Adjustments to the internal investment structure and project delays were approved in June 2022, maintaining the total investment amount and planned use of funds [2]. Surplus Fund Usage - The company plans to use RMB 15 million annually for permanent working capital supplementation, with RMB 10.57 million of surplus funds (including bank interest) allocated for this purpose in 2023 [4]. - The total surplus funds amount to RMB 29.52 million, which includes interest income [7]. Project Completion and Surplus Fund Situation - The completed fundraising projects include upgrades to the smart distribution network monitoring system, smart vending control system, R&D center construction, and others, with a total of RMB 24.63 million utilized [5][6]. - The remaining surplus funds will be permanently supplemented into working capital for daily operations [7]. Approval Process - The board and supervisory committee approved the proposal to conclude the fundraising projects and permanently supplement the surplus funds into working capital [6]. Sponsor's Verification Opinion - The sponsor believes that the decision to conclude the fundraising projects and permanently supplement the surplus funds is beneficial for improving fund utilization efficiency and does not adversely affect the company's operations or shareholder interests [8].
源飞宠物: 光大证券股份有限公司关于温州源飞宠物玩具制品股份有限公司首次公开发行前已发行股份部分解除限售上市流通的核查意见
Zheng Quan Zhi Xing· 2025-08-21 16:39
首次公开发行前已发行股份部分解除限售上市流通的核查意见 光大证券股份有限公司(以下简称"光大证券"或"保荐机构")作为温州 源飞宠物玩具制品股份有限公司(以下简称"源飞宠物"或"公司")持续督导 的保荐机构,根据《证券发行上市保荐业务管理办法》《深圳证券交易所股票上 市规则》《深圳证券交易所上市公司自律监管指引第 1 号——主板上市公司规范 运作》 《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等有关规 定,对源飞宠物首次公开发行前已发行股份部分解除限售并上市流通事项进行了 审慎核查,发表核查意见如下: 一、首次公开发行股份及上市后股本变动概况 (一)首次公开发行股份情况 经中国证券监督管理委员会(以下简称"中国证监会")《关于核准温州源飞 宠物玩具制品股份有限公司首次公开发行股票的批复》 (证监许可[2022]1280 号) 光大证券股份有限公司 关于温州源飞宠物玩具制品股份有限公司 核准,温州源飞宠物玩具制品股份有限公司(以下简称"公司"、"源飞宠物")首 次公开发行人民币普通股(A 股)34,100,000 股;经深圳证券交易所《关于温州 源飞宠物玩具制品股份有限公司人民币普通股股票上市 ...
光大证券研究所所长高瑞东辞任,将履新光大保德信基金总经理
2 1 Shi Ji Jing Ji Bao Dao· 2025-08-21 12:33
Core Viewpoint - The recent personnel changes in the "Everbright System" involve Gao Ruidong stepping down as the head of Everbright Securities Research Institute to join Everbright Prudential Fund, indicating a shift from sell-side to buy-side roles in the financial industry [2][3][4]. Group 1: Personnel Changes - Gao Ruidong has resigned from his position as the head of Everbright Securities Research Institute and will take on a leadership role at Everbright Prudential Fund [2][3]. - Wang Yifeng, the deputy director and chief analyst of the financial industry, will take over the daily operations of the research institute [2][4]. - Gao Ruidong's background includes significant experience in macroeconomic research and various roles in policy research and academia [3][4]. Group 2: Company Background - Everbright Prudential Fund is a joint public fund established in 2004, with a registered capital of 160 million RMB, where Everbright Securities holds a 55% stake [7]. - The fund's total assets were reported at 1.651 billion RMB, with net assets of 1.446 billion RMB as of the end of 2024 [7]. - As of the second quarter of this year, the fund's public fund asset scale was 79.136 billion RMB, ranking 68th in the industry [7]. Group 3: Performance and Future Outlook - Everbright Prudential Fund has shown strong performance in fixed income investments, ranking first in absolute returns over the past year and ten years [8]. - The fund's fixed income products accounted for over 80% of its non-monetary fund scale, indicating a focus on bond funds [7][8]. - With Gao Ruidong's leadership, the fund is expected to leverage its research capabilities and institutional sales experience for future growth [8].
莱茵生物: 1-1 光大证券股份有限公司关于桂林莱茵生物科技股份有限公司缩减部分募集资金投资规模、结项募投项目并将节余募集资金永久补充流动资金的核查意见
Zheng Quan Zhi Xing· 2025-08-21 12:18
Core Viewpoint - The company, Guilin Rhine Biotechnology Co., Ltd., is reducing the investment scale of certain fundraising projects and will permanently supplement its working capital with the remaining funds from these projects [2][10]. Fundraising Overview - The company raised a net amount of approximately 961.11 million RMB from a non-public stock issuance, which was approved by the China Securities Regulatory Commission [2]. - The funds were deposited in a dedicated account, and the management of these funds adheres to relevant regulations to ensure proper usage [3]. Fund Management and Usage - As of July 31, 2025, the total balance in the fundraising account was 1.63 million RMB, with a total interest income of approximately 1.48 million RMB [3]. - The company has directly invested approximately 652.66 million RMB into various projects, including 573.96 million RMB for the Stevia Extraction Factory and 78.70 million RMB for the Rhine Natural Health Products Research Institute [3][4]. Project Completion and Fund Reduction - The Stevia Extraction Factory project has met the completion criteria, with a total investment of 573.96 million RMB, leaving a surplus of approximately 36.32 million RMB [7][9]. - The Rhine Natural Health Products Research Institute project has been partially completed, with 78.70 million RMB invested and an estimated remaining payment of 37.08 million RMB [8][9]. Impact of Fund Reduction - The decision to reduce the investment scale and reallocate surplus funds is aimed at enhancing the company's liquidity and financial structure, thereby supporting sustainable development and maximizing shareholder value [10][9]. - The company’s current research and development capabilities are deemed sufficient to support ongoing business operations and future product innovations [9]. Approval Process - The board of directors and the supervisory board have approved the proposal to reduce the investment scale and reallocate surplus funds, which will be submitted for shareholder approval [10][11].
光大证券,重要人事变动!研究所所长高瑞东离职,下一站曝光
券商中国· 2025-08-21 08:48
"光大系"重要人事变动。 证券时报·券商中国记者从业内获悉,光大证券研究所所长、首席经济学家、机构业务总部总经理高瑞东近期将加盟光大 保德信基金,拟任光大保德信基金党总支部书记,后续或进一步接任总经理一职。 此外,券商中国记者获悉,高瑞东调任后,未来光大证券研究所或由副所长、金融业首席分析师王一峰执掌。王一峰具 有20年金融业从业经验,曾任中国民生银行研究院金融发展研究中心主任,先后供职于中信证券投资银行委员会、中信 证券研究部等。中证协信息显示,他于2019年5月加入光大证券。 高瑞东从光大证券离职 8月21日,券商中国记者获悉,光大证券研究所所长高瑞东已经正式从光大证券离职。 履历显示,高瑞东是光大证券首席经济学家,研究所所长,董事总经理,早稻田大学经济学博士,中国财政部金融人才 库专家,中国金融四十人青年论坛会员,中国证券业协会首席经济学家委员会委员,曾任职于中国财政部中美经济对话 领导小组办公室、OECD经济部、早稻田大学政治经济学院,专注全球和中国宏观经济与金融市场研究。2023年10月参 加国务院总理主持召开的经济形势专家和企业家座谈会,对经济工作建言献策。 在加盟光大证券之前,高瑞东曾先后任职于 ...
从卖方到买方,光大证券首席经济学家高瑞东或调任光大保德信基金
Xin Lang Zheng Quan· 2025-08-21 08:16
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 责任编辑:杨赐 据公开消息,光大证券首席经济学家、研究所所长高瑞东近日卸任,研究所日常事务将由副所长、金融 业首席分析师王一峰接管。高瑞东离任后有望出任光大保德信基金公司总经理,任命待完成公司内部程 序并获监管批准后生效。 履历显示,高瑞东系早稻田大学经济学博士,是中国财政部金融人才库专家、中国金融四十人青年论坛 成员,并担任中国证券业协会首席经济学家委员会委员。其职业履历横跨政策研究、国际组织与学界: 曾在中国财政部中美经济对话领导小组办公室、经济合作与发展组织(OECD)经济部、早稻田大学政 治经济学院等任职,长期聚焦全球与中国宏观经济及金融市场研究。2023年10月,高瑞东受邀参加国务 院总理主持召开的经济形势专家和企业家座谈会,并就经济工作建言献策。 ...